| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 01/20/2005 | US20050014815 Substituted 2-pyrrolidine-2-yl-1H-indole compounds |
| 01/20/2005 | US20050014813 High yield; synthetic pharmaceutical intermediate; diabetes, insulin sensitizers |
| 01/20/2005 | US20050014812 Benzimidazole compounds |
| 01/20/2005 | US20050014811 Such as 4-cyclopentylamino-benzenesulfonic acid 2-(3,4-dimethoxy-phenylamino)-1H-benzoimidazol-5-yl ester; cyclin-dependent kinase inhibitors that are aimed to be more active than flavopiridol |
| 01/20/2005 | US20050014807 Therapeutic compounds for treating dyslipidemic conditions |
| 01/20/2005 | US20050014806 Substituted isoxazoles and their use as antibiotics |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014802 Prevent reproduction of virus; antitumor agents |
| 01/20/2005 | US20050014788 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially ccr5) |
| 01/20/2005 | US20050014786 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 01/20/2005 | US20050014772 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 01/20/2005 | US20050014750 Isochroman compounds for treatment of cns disorders |
| 01/20/2005 | US20050014749 Piperazine derivatives and methods of use |
| 01/20/2005 | US20050014748 N-type calcium channel blockers |
| 01/20/2005 | US20050014746 compounds which bind to the interaction-domain (I-domain) of LFA-1, thus interrupting endothelial cell-leukocyte adhesion by blocking the interaction of LFA-1 with ICAM-1, ICAM-3, and other adhesion molecules |
| 01/20/2005 | US20050014745 Such as 3-[[4-(4-chlorophenyl)-2-thiazolyl]methoxy]-N-propyl-benzenemethanamine; nicotinamide adenine dinucleotide oxidase hydride donor inhibitors |
| 01/20/2005 | US20050014700 Cbi analogues of cc-1065 and the duocarmycins |
| 01/20/2005 | US20050014650 Delta 1-pyrrolines used as pesticides |
| 01/20/2005 | DE10329457A1 New 1,2-bis-phenylaminocarbonyl-pyrrolidine derivatives, useful for treating or preventing e.g. thrombosis, myocardial infarct and arteriosclerosis, are inhibitors of coagulation factor Xa |
| 01/20/2005 | DE102004014061A1 Amid-substituierte 1,2,4-Triazin-5(2H)-one Amide substituted 1,2,4-triazine-5 (2H) -ones |
| 01/20/2005 | CA2532056A1 Pyrrole-2, 5-dione derivatives as liver x receptor modulators |
| 01/20/2005 | CA2531485A1 Malonamide derivatives |
| 01/20/2005 | CA2531418A1 Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds |
| 01/20/2005 | CA2530455A1 Thiazolo-, oxazalo and imidazolo-quinazoline compounds capable of inhibiting protein kinases |
| 01/20/2005 | CA2530312A1 Arylamine-substituted quinazolinone compounds |
| 01/20/2005 | CA2530025A1 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 01/20/2005 | CA2529294A1 Oxazolidinone antibiotics and derivatives thereof |
| 01/20/2005 | CA2529293A1 Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof |
| 01/20/2005 | CA2529292A1 Oxazolidinone antibiotics and derivatives thereof |
| 01/19/2005 | EP1498419A1 Process for preparing alkali metal salts of hydrophobic sulfonamides |
| 01/19/2005 | EP1498418A1 Sulfonamides for treatment of endothelin-mediated disorders |
| 01/19/2005 | EP1498417A1 Heterocyclic amide derivatives |
| 01/19/2005 | EP1497672A2 Ultrasonic doppler effect speed measurement |
| 01/19/2005 | EP1497287A1 Quinolinone derivatives |
| 01/19/2005 | EP1497286A1 3-cyclyl-5-(nitrogen-containing 5-membered ring) methyl-oxazolidinone derivatives and their use as antibacterial agents |
| 01/19/2005 | EP1497285A1 Benzoxazinone-derived compounds, their preparation und use as medicaments |
| 01/19/2005 | EP1497271A1 Indane acetic acid derivatives and their use as pharmaceutical agents |
| 01/19/2005 | EP1497240A1 Non-heating clay composites for building materials |
| 01/19/2005 | EP1496910A1 Kinase inhibitors |
| 01/19/2005 | EP1496898A2 Tyrosine kinase inhibitors |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1317511B1 Oxazine derivatives |
| 01/19/2005 | EP0958293B1 Nanomolar, non-peptide inhibitors of cathepsin d |
| 01/19/2005 | CN1568323A Activator for peroxisome proliferator-activated receptor delta |
| 01/19/2005 | CN1568322A Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases |
| 01/19/2005 | CN1568321A Novel substituted 4-phenyl-4-ú¿1h-imidazol-2-ylú®-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/19/2005 | CN1568187A 2H-2, 3-dinitrogen phenodiazine-1-ketone and using method thereof |
| 01/19/2005 | CN1568186A Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ischaemic damage |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1568144A Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1185234C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 01/19/2005 | CN1185217C Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/19/2005 | CN1185216C Fungicides |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 01/18/2005 | US6844342 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 01/18/2005 | US6844295 2-Pyridin-2-yl derivatives |
| 01/13/2005 | WO2005003127A1 Bicyclic heteroaromatic derivatives as modulators of cxcr3 function |
| 01/13/2005 | WO2005003123A1 Novel pyridine derivatives as jnk specific inhibitors |
| 01/13/2005 | WO2005003118A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronically inflammatory diseases |
| 01/13/2005 | WO2005003099A2 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/13/2005 | WO2005003097A1 Cis-2,4,5-triaryl-imidazolines |
| 01/13/2005 | WO2005003087A2 Oxazole derivatives as antibacterial agents |
| 01/13/2005 | WO2005002577A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | WO2005002552A2 Benzimidazole derivatives and their use as protein kinases inhibitors |
| 01/13/2005 | WO2005002503A2 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | WO2004092130A3 N-containing heteroaromatic compounds as modulators of ppars and methods of treating metabolic disorders |
| 01/13/2005 | WO2004087880A8 Compounds and their use to treat diabetes and related disorders |
| 01/13/2005 | WO2004082623A3 Substituted piperidine compounds |
| 01/13/2005 | WO2004064764A3 Substituted alkyl amido piperidines |
| 01/13/2005 | US20050009894 Benzimidazole derivatives and their use as KDR kinase protein inhibitors |
| 01/13/2005 | US20050009892 Phenyloxazole derivatives lower blood triglyceride, glucose, insulin; hyperlipidemia, arteriosclerosis, diabetes mellitus, hypertension, obesity; 2-methyl-2-[6-(5-methyl-2-phenyloxazol-4-yl)-(E)-4-hexenyloxy]propionic acid |
| 01/13/2005 | US20050009876 Indazole compounds, compositions thereof and methods of treatment therewith |
| 01/13/2005 | US20050009870 3-(amino)sulfonylamino-substituted, e.g., N-(1,6-Dibenzyl-2-oxo-1,2,3,4-tetrahydroquinolin-3-yl)-benzenesulfonamide and N-(1-Benzyl-2-oxo-6-(thiophen-3-yl)-1,2,3,4-tetrahydroquinolin-3-yl)benzenesulfonamide; eating, metabolic, obesity, cognitive, neurological, pain, inflammatory and psychiatric disorders |
| 01/13/2005 | US20050009855 1-(hydroxy, oxo, or epoxy)-3-oxo-3'-benzaminocarbonyl-4'-(carboxy or carboxylate)-1,2,3-trihydroindene-2-spiro-2'-tetrahydrofuran derivatives; these compounds interfere with the E1-E2-DNA complex during initiation of DNA replication |
| 01/13/2005 | US20050009853 Pyrimidine derivatives for the treatment of abnormal cell growth |
| 01/13/2005 | US20050009840 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer |
| 01/13/2005 | US20050009838 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors |
| 01/13/2005 | US20050009829 1-Substituted 2-carboxamide derivatives of fused ring imidazoles, e.g., -[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-1H-benzoimidazole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide |
| 01/13/2005 | US20050009827 Triazole-derivatives as factor Xa inhibitors |
| 01/13/2005 | US20050009820 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 01/13/2005 | US20050009818 Therapeutic heterocyclic compounds |
| 01/13/2005 | US20050009815 4-Aminoquinoline compounds |
| 01/13/2005 | US20050009785 Heterocyclic compounds |
| 01/13/2005 | US20050009784 2-(p-oxyphenyl)-6-oxyquinolines, e.g., 2-(3-Fluoro-4-hydroxyphenyl)-4-phenylquinolin-6-ol |
| 01/13/2005 | US20050009058 Nitro-substituted non-fluorescent asymmetric cyanine dye compounds |
| 01/13/2005 | CA2531061A1 Pyrimidines useful as modulators of voltage-gated ion channels |
| 01/13/2005 | CA2531050A1 Pharmaceutical compounds |
| 01/13/2005 | CA2530886A1 Dual nk1/nk3 antagonists for treating schizophrenia |
| 01/13/2005 | CA2530816A1 Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronic inflammatory diseases |
| 01/13/2005 | CA2528119A1 Cis-2,4,5-triaryl-imidazolines |
| 01/13/2005 | CA2525580A1 Asymmetric benzimidazoles and related compounds as potassium channel modulators |
| 01/12/2005 | EP1495021A2 Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/12/2005 | EP1495020A1 N-(morpholin-2yl) methyl acetamide derivatives as ccr-3 antagonists useful in the treatment of inflammatory diseases |
| 01/12/2005 | EP1495011A1 A semi-synthetic process for the preparation of n debenzoylpaclitaxel |
| 01/12/2005 | EP1495007A1 Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses |
| 01/12/2005 | EP1495003A1 Fredericamycin derivatives |
| 01/12/2005 | EP1495002A1 Benzamide derivatives useful as histone deacetylase inhibitors |